Global X Genomics & Biotechnology ETF
GNOM
10 hedge funds and large institutions have $13M invested in Global X Genomics & Biotechnology ETF in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 6 → 10 (+4)
32% more capital invested
Capital invested by funds: $9.83M → $13M (+$3.19M)
1.05% less ownership
Funds ownership: 17.09% → 16.03% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$438K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$180K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$48.9K |
| 4 |
APA
American Portfolios Advisors
Holbrook,
New York
|
+$8.93K |
| 5 |
AA
Advisory Alpha
Holland,
Michigan
|
+$2.18K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Citigroup
New York
| $11.7M | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $560K | +$180K | +3,151 | +54% |
|
|
3
Jane Street
New York
| $477K | +$438K | +7,645 | New |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $145K | +$1.15K | +20 | +0.9% |
|
|
5
UBS Group
Zurich,
Switzerland
| $53K | +$48.9K | +854 | New |
|
|
AA
6
Advisory Alpha
Holland,
Michigan
| $30.6K | +$2.18K | +38 | +8% |
|
7
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $24K | – | – | – |
|
|
BFEC
8
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $12K | +$1.6K | +28 | +17% |
|
|
APA
9
American Portfolios Advisors
Holbrook,
New York
| $9.76K | +$8.93K | +156 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $2K | +$1.66K | +29 | New |
|
GNOM Hedge Fund Activity: Q4 2019 in Review
10 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q4 2019, worth a combined $13M — up 32% from $9.83M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GNOM positions and 0 closed out — a net gain of 4 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $438K.
- 10 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q4 2019, up from 6 in Q3 2019.
- Funds reported $13M of Global X Genomics & Biotechnology ETF stock for Q4 2019, up 32% quarter-over-quarter.
- 4 funds opened new Global X Genomics & Biotechnology ETF positions in Q4 2019 and 0 closed out, a net change of +4 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q4 2019 was Jane Street, an estimated $438K added.
Based on aggregated 13F filings for Q4 2019.